Sign Up Today and Learn More About Transition Bio Stock
Invest in or calculate the value of your shares in Transition Bio or other pre-IPO companies through EquityZen's platform.
Transition Bio Stock (TRNB)
Transition Bio provides condensate technology for drug discovery and diagnostics.
About Transition Bio Stock
Founded
2020
Headquarters
Cambridge, MA, US
Industries
Blockchain and Crypto, Internet Services, Commerce and Shopping
Transition Bio Press Mentions
Stay in the know about the latest news on Transition Bio
Voyager, Transition Bio set sail on neuro research trek in search of small molecule candidates
fiercebiotech • Nov 14, 2025
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
biospace • Nov 11, 2025
Voyager Reports Third Quarter 2025 Financial and Operating Results
biospace • Nov 11, 2025
Voyager Therapeutics, Transition Bio entered into drug discovery collab
thefly • Nov 11, 2025
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
globenewswire • Nov 10, 2025
Transition Bio Management
Leadership team at Transition Bio
Chairman
Kelly Martin
Chief Operating Officer
Martin Kulander
Join now and verify your accreditation status to gain access to:
- Transition Bio Current Valuation
- Transition Bio Stock Price
- Transition Bio Management
- Available deals in Transition Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Transition Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Transition Bio Revenue and Financials
- Transition Bio Highlights
- Transition Bio Business Model
- Transition Bio Risk Factors
- Transition Bio Research Report from SACRA Research
Trading Transition Bio Stock
How to invest in Transition Bio stock?
Accredited investors can buy pre-IPO stock in companies like Transition Bio through EquityZen funds. These investments are made available by existing Transition Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Transition Bio stock?
Shareholders can sell their Transition Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
